VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Bortezomib
Related studies linked through entity extraction aliases.
Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies.
- Status
- COMPLETED
- Phase
- N/A
Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2
The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer)
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Rituximab in Treating Patients With Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
An Efficacy and Safety Study of Bortezomib Re-treatment in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Bortezomib in Patients With Advanced Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Bendamustine and Bortezomib Combination Therapy in Indolent Non-Hodgkin's Lymphoma(NHL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Bortezomib and Rituximab in Patients With Waldenstrom's Macroglobulinemia (WM)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE3
Bortezomib and Carboplatin in Treating Patients With Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Bortezomib as Consolidation Therapy in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Consolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Bortezomib and Low Dose Cytarabine in the Treatment of High-risk Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2